Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
High blood pressure
Pharma
ICER says AZ's Baxfendy doesn't clear its cost-effectiveness bar
AZ’s newly approved blood pressure drug Baxfendy does not clear the bar for effectiveness relative to its price, says U.S. drug price watchdog ICER.
Kevin Dunleavy
Aug 13, 2026 11:37am
AZ nets key hypertension nod for Baxfendy, plus new Fasenra use
May 18, 2026 11:23am
Granules recalls blood pressure med for failing to meet specs
Jul 9, 2025 8:46am
George Medicines' triple-combo blood pressure med wins FDA nod
Jun 9, 2025 11:13am
Lupin recalls 600K bottles of blood pressure med
Nov 25, 2024 1:20pm
George Medicines' combo hypertension prospect posts strong data
Aug 31, 2024 4:00am
